A pharmacodynamic model for soman in the rat.

A pharmacodynamic model for inhibition of acetylcholinesterase (AChE) by soman was developed to describe the intertissue differences in AChE inhibition, the dose response of AChE to inhibition by soman, and the effect of differences in xenobiotic metabolism on soman toxicity. Based on the principles of physiological pharmacokinetics, this pharmacodynamic model consisted of a set of mass balance equations that included parameters for blood flow, tissue volumes, soman metabolism, tissue/plasma partition coefficients, initial AChE levels, and the rate constant for AChE inhibition. Sensitivity analysis of the model revealed that variation of the soman metabolism parameter in plasma was the most important determinant of variation in the inhibition of brain AChE by soman.

[1]  D. M. Maxwell,et al.  The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats. , 1987, Toxicology and applied pharmacology.

[2]  I. L. Natoff,et al.  Organophosphorus pesticides: pharmacology. , 1971, Progress in medicinal chemistry.

[3]  R K Jain,et al.  Physiologically based pharmacokinetic modeling: principles and applications. , 1983, Journal of pharmaceutical sciences.

[4]  O. Wolthuis,et al.  Evidence for an intramuscular depot of the cholinesterase inhibitor soman in the rat. , 1983, European journal of pharmacology.

[5]  John Leyden. Webb,et al.  Enzyme and metabolic inhibitors , 1963 .

[6]  B. J. Winer.  Statistical Principles in Experimental Design , 1992 .

[7]  A. L. Green.  The kinetic basis of organophosphate poisoning and its treatment , 1958 .

[8]  S. Snyder,et al.  Muscarinic cholinergic binding in rat brain. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Ecobichon Dj.  Characterization of the esterases of feline serum. , 1970 .

[10]  E. Diliberto,et al.  Selective, near-total, irreversible inactivation of peripheral pseudocholinesterase and acetylcholinesterase in cats in vivo. , 1974, Biochemical pharmacology.

[11]  J. Genderen,et al.  Isolation, in Vitro Activity, and Acute Toxicity in Mice of the Four Stereoisomers of Soman , 1984 .

[12]  J. Clement.  Role of aliesterase in organophosphate poisoning , 1984 .

[13]  D. Gay,et al.  Stereospecificity and active site requirements in a diisopropylphosphorofluoridate-hydrolyzing enzyme. , 1979, Biochemical pharmacology.

[14]  O. Wolthuis,et al.  Stereoisomers of soman (pinacolyl methylphosphonofluoridate): inhibition of serum carboxylic ester hydrolase and potentiation of their toxicity by CBDP (2-(2-methylphenoxy)-4H-1,3,2-benzodioxaphosphorin-2-oxide) in mice. , 1987, Toxicology and Applied Pharmacology.

[15]  R. Dawson,et al.  Kinetic constants for the inhibition of eel and rabbit brain acetylcholinesterase by some organophosphates and carbamates of military significance. , 1987, Toxicology and applied pharmacology.

[16]  F. Fonnum,et al.  A method for generating toxic vapors of soman: toxicity of soman by inhalation in rats. , 1985, Toxicology and applied pharmacology.

[17]  D. M. Maxwell,et al.  The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. , 1987, Toxicology letters.

[18]  A. Siakotos,et al.  A specific radioisotopic assay for acetylcholinesterase and pseudocholinesterase in brain and plasma , 1969 .

[19]  E. Reiner,et al.  Effect of pH on inhibition and spontaneous reactivation of acetylcholinesterase treated with esters of phosphorus acids and of carbamic acids. , 1967, The Biochemical journal.

[20]  P. Little,et al.  Relationship between the biodisposition of [3H]soman and its pharmacological effects in mice. , 1985, Toxicology and applied pharmacology.

[21]  F. Fonnum,et al.  Inhibition of acetylcholinesterase from different species by organophosphorus compounds, carbamates and methylsulphonyfluoride. , 1977, General pharmacology.

[22]  L. D. de Jong,et al.  Toxicokinetics of the four stereoisomers of the nerve agent soman in atropinized rats--influence of a soman simulator. , 1987, Toxicology and applied pharmacology.

[23]  H. Benschop,et al.  GLC-analysis and pharmacokinetics of the four stereoisomers of soman , 1981 .

[24]  E. H. Twizell.  The mathematical modeling of metabolic and endocrine systems: E.R. Carson, C. Cobelli and L. Finkelstein John Wiley and Sons, Chichester, Sussex, UK, 394 pp., £45.15, 1983 , 1984 .

[25]  R. Brimblecombe.  Drugs acting on central cholinergic mechanisms and affecting respiration. , 1977, Pharmacology & therapeutics. Part B: General & systematic pharmacology.

[26]  A. Hindmarsh,et al.  GEAR: ORDINARY DIFFERENTIAL EQUATION SYSTEM SOLVER. , 1971 .

[27]  A. Ooms,et al.  The reaction of organophosphorus compounds with hydrolytic enzymes. The inhibition of horse liver aliesterase. , 1965, Biochemical pharmacology.

[28]  W. Junge,et al.  The carboxylesterases/amidases of mammalian liver and their possible significance. , 1975, CRC critical reviews in toxicology.

[29]  J. S. Little.  Isolation and partial characterization of plasma membranes from the livers of control and Streptococcus pneumoniae-infected rats , 1977, Infection and immunity.